title: Iowa patients want new anti-obesity drug.
abstract: The media has been rife with stories about dexfenfluramine, the newest anti-obesity drug. The predictable result of this media coverage is that many patients are asking their physicians for the drug. In a special Q & A feature, a Des Moines family physician writes about the latest diet pill and a special ad hoc committee formed at his clinic.
authors.affiliation: Mercy West Medical Clinic, Des Moines, USA.
authors.forename: W
authors.initials: W
authors.lastname: Belling
mesh_terms: D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D004038:Diet, Reducing; D005277:Fenfluramine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000178:diet therapy / Q000188:drug therapy*; D010353:Patient Education as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015431:Weight Loss
chemical_list: D001067:Appetite Depressants; D005277:Fenfluramine; D017367:Selective Serotonin Reuptake Inhibitors